$MDCX
Medicus Pharma Ltd. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.173
▲+10.50%+$0.016
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMedicus Pharma Ltd. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is MDCX up today? It is at $0.173 (+10.50%), and our scanner flagged it 94 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MDCX spikes, and full due diligence on MDCX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MDCX 94 times in the last 30 days. Create a free account to track $MDCX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MDCX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystAgreement Terminated, from an SEC filing. Read it →Latest filingSC 13DActivist 5%+ stake disclosedSep 14, 2026 · 3 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bokhari Raza Officer | Acquired (grant/award) | +2.94M 4.7% of company | n/a | 2.94M | $500K at $0.170 | Sep 4, 26 |
Bonner Carolyn F. Officer | Acquired (grant/award) | +1.47M 2.3% of company | added 100% | 1.49M | $250K at $0.170 | Sep 4, 26 |
Brennan Edward J. Officer | Acquired (grant/award) | +588K 0.9% of company | added 100% | 675K | $100K at $0.170 | Sep 4, 26 |
Mehmud Faisal Officer | Acquired (grant/award) | +1.47M 2.3% of company | n/a | 1.47M | $250K at $0.170 | Sep 4, 26 |
Smith Andrew Alasdair Officer | Acquired (grant/award) | +735K 1.2% of company | added 100% | 735K | $125K at $0.170 | Sep 4, 26 |
Quinlan James P. Officer | Other | 145K 0.2% of company | added 100% | 274K | $117K at $0.810 | Aug 13, 25 |
Velocity Fund Partners, Lp Beneficial Owner (10%) | Sold (automatic/other) | -75K 0.1% of company | sold 2.3% | 3.25M | $579K at $7.72 | May 20, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MDCX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
MDCX last traded at $0.173, up 10.50% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The MDCX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MDCX 94 times in the last 30 days.
MDCX (Medicus Pharma Ltd. Common Stock) trades on XNAS, with a market cap of about $10M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MDCX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MDCX discussion
Sign in to ask a question or join the discussion.